<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VET</journal-id>
<journal-id journal-id-type="hwp">spvet</journal-id>
<journal-id journal-id-type="nlm-ta">Vet Pathol</journal-id>
<journal-title>Veterinary Pathology</journal-title>
<issn pub-type="ppub">0300-9858</issn>
<issn pub-type="epub">1544-4221</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300985811427152</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300985811427152</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetic Diseases and Functional Anatomy</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Immunohistochemical Characteristics of Normal Canine Eyes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Labelle</surname>
<given-names>P.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0300985811427152">1</xref>
<xref ref-type="corresp" rid="corresp1-0300985811427152"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reilly</surname>
<given-names>C. M.</given-names>
</name>
<xref ref-type="aff" rid="aff2-0300985811427152">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Naydan</surname>
<given-names>D. K.</given-names>
</name>
<xref ref-type="aff" rid="aff2-0300985811427152">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Labelle</surname>
<given-names>A. L.</given-names>
</name>
<xref ref-type="aff" rid="aff3-0300985811427152">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0300985811427152">
<label>1</label>Antech Diagnostics, Lake Success, New York</aff>
<aff id="aff2-0300985811427152">
<label>2</label>Department of Pathology, Microbiology, and Immunology, University of California–Davis, Davis, California</aff>
<aff id="aff3-0300985811427152">
<label>3</label>Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois–Urbana-Champaign, Urbana, Illinois</aff>
<author-notes>
<corresp id="corresp1-0300985811427152">Philippe Labelle, Antech Diagnostics, 1111 Marcus Ave M28, Lake Success , NY 11042 Email: <email>philippe.labelle@vcaantech.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>49</volume>
<issue>5</issue>
<fpage>860</fpage>
<lpage>869</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American College of Veterinary Pathologists</copyright-holder>
</permissions>
<abstract>
<p>Immunohistochemistry is widely utilized in diagnostic laboratories to study neoplastic and nonneoplastic diseases. Knowledge of the immunohistochemical characteristics of normal tissue is essential for interpretation of immunoreactivity in pathologic conditions. In this study, immunohistochemistry was performed with a broad panel of diagnostically relevant antibodies on 4 normal canine globes—namely, vimentin, pan-cytokeratin (AE1/AE3), cytokeratin 7, cytokeratin 8/18, cytokeratin 20, α–smooth muscle actin, muscle specific actin, desmin, Melan-A, microphthalmia transcription factor, S-100, glial fibrillary acidic protein, triple neurofilaments, neuron-specific enolase, chromogranin A, synaptophysin, laminin and CD31. Results include cytokeratin immunoreactivity limited to the conjunctival epithelium, corneal epithelium, and retinal pigment epithelium; distinct patterns of immunopositivity of muscle markers; and widespread immunoreactivity for vimentin and most neural/neuroendocrine markers. These findings in normal eyes provide the basis for interpretation of ocular immunohistochemistry in dogs. Published immunophenotypes of primary ocular neoplasms are also reviewed.</p>
</abstract>
<kwd-group>
<kwd>dogs</kwd>
<kwd>eye</kwd>
<kwd>immunohistochemistry</kwd>
<kwd>neoplasms</kwd>
<kwd>review</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Immunohistochemistry has been used in various forms since the early 1940s to identify cell types, structures, organisms, and materials secreted by cells.<sup>
<xref ref-type="bibr" rid="bibr13-0300985811427152">13</xref>,<xref ref-type="bibr" rid="bibr38-0300985811427152">38</xref>,<xref ref-type="bibr" rid="bibr57-0300985811427152">57</xref>,<xref ref-type="bibr" rid="bibr74-0300985811427152">74</xref>
</sup> In diagnostic settings, immunohistochemistry is most often used to determine the histogenesis of neoplasms, characterize neoplastic subtypes, or establish prognosis.<sup>
<xref ref-type="bibr" rid="bibr38-0300985811427152">38</xref>,<xref ref-type="bibr" rid="bibr74-0300985811427152">74</xref>
</sup> In one human study, immunohistochemistry was performed to establish a diagnosis in 64% of cases, determine prognosis in 19% of cases, and identify microorganisms or acellular structures in 17% of cases.<sup>
<xref ref-type="bibr" rid="bibr74-0300985811427152">74</xref>
</sup>
</p>
<p>Antibodies that may be beneficial in diagnostic ocular pathology are similar to those of value in other organs. Antibodies directed against intermediate filaments (IFs), such as cytokeratins (CKs), vimentin, desmin, glial fibrillary acidic protein (GFAP), and neurofilaments, may be useful. CKs are classified as type I or II IFs and are typical of epithelial cells.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>
</sup> Antibodies can target individual CKs or groups of CKs, such as AE1/AE3. Vimentin, a type III IF, is the major IF of nonmyocyte mesenchymal cells. It is commonly coimmunoreactive with other IFs.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr35-0300985811427152">35</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>
</sup> Desmin, a type III IF, is found mostly in striated, myocardial, and smooth muscle cells.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr35-0300985811427152">35</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>
</sup> GFAP is immunoreactive in glial cells and can be coimmunopositive with CKs in some epithelial cells. GFAP is also a type III IF.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>
</sup> Neurofilaments (triple neurofilaments [TNF]) are type IV IFs and consist of a triplet of proteins in neural tissues and a subset of neuroendocrine cells.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr35-0300985811427152">35</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>
</sup> Actin microfilaments can be identified using antibodies that recognize either all 4 muscle actins (HHF35/muscle-specific actin [MSA]) or only α–smooth muscle actin (SMA).<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>
</sup>
</p>
<p>Melanocytic markers, such as Melan-A and microophthalmia transcription factor (MITF), may also be helpful in diagnostic immunohistochemistry. The Melan-A antibody targets an antigen that is recognized by autologous cytotoxic T cells and is mostly used in the diagnosis of melanoma, although Melan-A is also immunoreactive in nonmelanocytic cells.<sup><xref ref-type="bibr" rid="bibr58-0300985811427152">58</xref>,<xref ref-type="bibr" rid="bibr59-0300985811427152">59</xref></sup> MITF is a protein essential for the synthesis of melanin pigment as well as the embryogenesis and postnatal survival of melanocytes.<sup><xref ref-type="bibr" rid="bibr26-0300985811427152">26</xref></sup> Other helpful neural/neuroendocrine markers include S100, neuron-specific enolase (NSE), synaptophysin and chromogranin A. S100 is a calcium-binding protein that is utilized in the diagnosis of melanoma; however, S100 antibodies also stain a variety of normal tissues and nonmelanocytic neoplasms.<sup><xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr59-0300985811427152">59</xref>,<xref ref-type="bibr" rid="bibr67-0300985811427152">67</xref></sup> NSE is a glycolytic isoenzyme present in neurons, neuroendocrine cells, and other cell types, including smooth muscle.<sup>
<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>,<xref ref-type="bibr" rid="bibr59-0300985811427152">59</xref>,<xref ref-type="bibr" rid="bibr67-0300985811427152">67</xref>
</sup> Synaptophysin is a membrane glycoprotein of presynaptic vesicles of neurons and neuroendocrine cells.<sup>
<xref ref-type="bibr" rid="bibr2-0300985811427152">2</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>
</sup> Chromogranins are the major proteins in neurosecretory granules of neuroendocrine cells and sympathetic nerves.<sup>
<xref ref-type="bibr" rid="bibr2-0300985811427152">2</xref>,<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>
</sup> Laminin is a glycoprotein and a major component of basal lamina/basement membranes.<sup>
<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>
</sup> CD31, or PECAM-1, is normally immunoreactive in endothelium and some leukocytes.<sup>
<xref ref-type="bibr" rid="bibr36-0300985811427152">36</xref>
</sup>
</p>
<p>Accurate interpretation of immunohistochemical reactions in neoplastic and nonneoplastic lesions requires the knowledge of normal tissue’s immunohistochemical properties. There has been an exponential increase in the number of scientific publications using immunohistochemistry over the last several decades.<sup>
<xref ref-type="bibr" rid="bibr74-0300985811427152">74</xref>
</sup> Greater than 50% of all studies in the dog utilizing immunohistochemical techniques have been published since 2000, and 75% were published after 1990 (PubMed search performed January 18, 2011). Despite the ever-expanding utilization of immunohistochemistry, there has been little published on the immunohistochemical properties of normal eyes in animals. Only a few reports describe immunohistochemical findings of normal canine ocular structures. These reports examined specific diseases or structures and utilized a select number of antibodies (Supplemental Table 1, available online at <ext-link ext-link-type="uri" xlink:href="http://vet.sagepub.com/supplemental">http://vet.sagepub.com/supplemental</ext-link>). The purpose of this study was to characterize the immunohistochemical reactivity of antibodies routinely used in a diagnostic setting in normal canine globes.</p>
<sec id="section1-0300985811427152" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section2-0300985811427152">
<title>Animals</title>
<p>Four histologically normal globes were obtained from dogs with no known history of previous ocular disease and were euthanized for reasons unrelated to the study. All globes were from adult dogs (4–10 years): 1 was an intact male; 3 were neutered males. Breeds included 1 Pit Bull Terrier, 1 Pit Bull Terrier cross, 1 Labrador Retriever cross, and 1 Weimaraner. The globes with retrieved within 1 hour of euthanasia, fixed in 10% neutral buffered formalin for 24 to 48 hours, and routinely processed for histology.</p>
</sec>
<sec id="section3-0300985811427152">
<title>Immunohistochemistry</title>
<p>This study used antibodies against vimentin, pan-CK (AE1/AE3), CK7, CK8/18, CK20, SMA, MSA, desmin, Melan-A, MITF, S-100, GFAP, TNF, NSE, chromogranin A, synaptophysin, laminin, and CD31. A standard streptavidin–biotin horseradish peroxidase method was used. Antibodies, positive control, and antigen retrieval methods are listed in Supplemental Table 2. Briefly, tissues sections were deparaffinized with xylene and rehydrated using a graded ethanol series. Endogenous peroxidase activity was quenched by incubating sections in 0.3% H<sub>2</sub>O<sub>2</sub> in methanol for 30 minutes. Antigen retrieval was performed as noted in Supplemental Table 2. Sections were incubated in 3% normal goat serum for 30 minutes at room temperature. Sections were incubated with the primary antibody for 60 minutes or 2 hours (CD31) or overnight at 4°C (Melan-A) in a moist chamber. Slides were incubated with a biotinylated anti-mouse link reagent (Biocare Medical, Concord, CA) for 10 minutes and then incubated with streptavidin horseradish peroxidase (Biocare Medical) for 10 minutes. Positive reaction was visualized with 3-amino-9-ethylcarbazole chromogen (Zymed Labs, San Francisco, CA), followed by several rinses in phosphate buffered saline. Slides were counterstained with Mayer’s hematoxylin (Sigma Chemical Co., St. Louis, MO). Negative controls were prepared by substituting the primary antibody with an irrelevant species-matched antibody (monoclonal antibodies) or phosphate buffered saline (polyclonal antibodies) (Supplemental Table 2).</p>
<p>Sixty structures were evaluated for each globe. In addition to those listed in <xref ref-type="table" rid="table1-0300985811427152">Table 1</xref>, the following cells and structures were evaluated: collagen matrix (corneal, scleral, uveal), blood vessels and peripheral nerves of the uvea, lens zonules, nonvascular smooth muscle cells of the choroid,<sup>
<xref ref-type="bibr" rid="bibr40-0300985811427152">40</xref>,<xref ref-type="bibr" rid="bibr56-0300985811427152">56</xref>
</sup> and retinal muller cells. The ciliary epithelium of the pars plicata and pars plana were initially examined as separate sites but are combined in <xref ref-type="table" rid="table1-0300985811427152">Table 1</xref>. Similarly, the pigmented and nonpigmented retinal pigment epithelium (RPE) was initially examined separately. The immunoreactivity was assessed independently by 2 observers (P.L., C.M.R.). The immunoreactivity was noted to be positive when coloration was distributed appropriately within the cell/structure for each antibody. Positive reaction was moderate or strong unless noted to be weak. Other findings, such as distribution pattern, were noted separately.</p>
<table-wrap id="table1-0300985811427152" position="float">
<label>Table 1.</label>
<caption>
<p>Immunohistochemical Reactivity in Normal Canine Eyes<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0300985811427152" xlink:href="10.1177_0300985811427152-table1.tif"/>
<table>
<thead>
<tr>
<th>Structure/Antibody</th>
<th>Vimentin</th>
<th>AE1/AE3</th>
<th>CK8/18</th>
<th>SMA</th>
<th>MSA</th>
<th>Desmin</th>
<th>Melan-A</th>
<th>S100</th>
<th>NSE</th>
<th>GFAP</th>
<th>Syn</th>
<th>TNF</th>
<th>Laminin</th>
</tr>
</thead>
<tbody>
<tr>
<td>Limbus-sclera</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Superficial epithelium</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>1</td>
<td>Neg</td>
<td>1</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Basal cells</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>1</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>b</sup>
</td>
</tr>
<tr>
<td> Fibrocytes</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Melanocytes</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td>Cornea</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Superficial layers</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>1</td>
<td>Neg</td>
<td>1</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Basal cells</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>1</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>b</sup>
</td>
</tr>
<tr>
<td> Keratocytes</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>2<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Descemet membrane</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2</td>
</tr>
<tr>
<td> Endothelium</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>2</td>
<td>1</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td>Iris</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Stromal cells</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>c</sup>
</td>
</tr>
<tr>
<td> Melanocytes</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Constrictor muscle</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
</tr>
<tr>
<td> Dilator muscle</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>1</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
</tr>
<tr>
<td> Posterior epithelium</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td>Ciliary body</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Pectinate ligament cells</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>2</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>b,d</sup>
</td>
</tr>
<tr>
<td> Trabecular meshwork cells</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>b,d</sup>
</td>
</tr>
<tr>
<td> Nonpigmented epithelium</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>1</td>
<td>Neg</td>
<td>4<sup>b</sup>
</td>
</tr>
<tr>
<td> Pigmented epithelium</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>b</sup>
</td>
</tr>
<tr>
<td> Stromal cells</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>1</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Melanocytes</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Ciliary muscle</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>2</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
</tr>
<tr>
<td>Choroid</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Tapetum lucidum</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Stromal cells</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>c</sup>
</td>
<td>4<sup>c</sup>
</td>
<td>4<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Melanocytes</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td>Lens</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Lens epithelium</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>3</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Capsule</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2</td>
</tr>
<tr>
<td> Cortex</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>2</td>
<td>Neg</td>
<td>3</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Nucleus</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td>Retina</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Inner limiting membrane</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Nerve fiber layer</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
</tr>
<tr>
<td> Ganglion cells</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>2</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
</tr>
<tr>
<td> Inner plexiform layer</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
</tr>
<tr>
<td> Inner nuclear layer</td>
<td>4<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2<sup>c</sup>
</td>
<td>Neg</td>
<td>4<sup>c</sup>
</td>
<td>2<sup>c</sup>
</td>
<td>Neg</td>
</tr>
<tr>
<td> Outer plexiform layer</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>3</td>
<td>Neg</td>
</tr>
<tr>
<td> Outer nuclear layer</td>
<td>4<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>c</sup>
</td>
<td>Neg</td>
<td>4<sup>c</sup>
</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Outer limiting membrane</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Rod-cone layer</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>3</td>
<td>Neg</td>
</tr>
<tr>
<td> Retinal pigment epithelium</td>
<td>4</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>3</td>
<td>Neg</td>
<td>Neg</td>
<td>4<sup>b</sup>
</td>
</tr>
<tr>
<td>Optic nerve</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Axons</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2</td>
<td>4</td>
<td>4</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
</tr>
<tr>
<td> Glial cells</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
<td>2</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>Neg</td>
</tr>
<tr>
<td> Meninges</td>
<td>4</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
<td>Neg</td>
<td>1</td>
<td>3</td>
<td>Neg</td>
<td>3</td>
<td>2</td>
<td>Neg</td>
<td>Neg</td>
<td>4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300985811427152">
<p>CK, cytokeratin; SMA, α-smooth muscle actin; MSA, muscle-specific actin; NSE, neuron-specific enolase; GFAP, glial fibrillary acidic protein; Syn, synaptophysin; TNF, triple neurofilament.</p>
</fn>
<fn id="table-fn2-0300985811427152">
<p>
<sup>a</sup>Results listed as number of positive cases (out of 4); neg, all 4 cases were immunonegative.</p>
</fn>
<fn id="table-fn3-0300985811427152">
<p>
<sup>b</sup>Immunoreaction in the basement membrane.</p>
</fn>
<fn id="table-fn4-0300985811427152">
<p>
<sup>c</sup>Immunoreaction in some but not all cells.</p>
</fn>
<fn id="table-fn5-0300985811427152">
<p>
<sup>d</sup>Immunoreaction in the extracellular matrix.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section4-0300985811427152">
<title>Results</title>
<p>Results are summarized in <xref ref-type="table" rid="table1-0300985811427152">Table 1</xref>. The immunoreactivity of each stain was similar for the 4 globes in 97% of the cells/structures evaluated. There was no positive immunoreaction with CK7, CK20, or chromogranin A in any ocular structure. MITF immunoreactivity was present in melanocytes and RPE as expected, but there was also positive immunoreaction in almost all other structures evaluated, making conclusive interpretation impossible (results not shown).</p>
<sec id="section5-0300985811427152">
<title>Limbus</title>
<p>The conjunctival epithelium was immunopositive for AE1/AE3, SMA, and GFAP. In addition, the superficial cells were immunopositive for CK8/18 (basal cells were negative); there was weak immunoreactivity for desmin mostly in basal cells; and 1 case was weakly immunoreactive for S100 in the basal and superficial epithelium. In 2 cases, rare vimentin and Melan-A immunopositive cells were scattered in the epithelium (interpreted as melanocytes). The basement membrane was immunoreactive for laminin. In the substantia propria, the fibrocytes were vimentin immunopositive, and the melanocytes were vimentin and Melan-A immunoreactive.</p>
</sec>
<sec id="section6-0300985811427152">
<title>Cornea</title>
<p>The basal cells and superficial layers (wing and superficial cells) of the epithelium were immunopositive for AE1/AE3, CK8/18, SMA, and GFAP (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 1a–1c</xref>). There was weak immunoreaction for desmin and S100 (3 cases), mostly in basal cells, and 1 case was weakly immunoreactive for MSA in the basal cells. In 1 case, a small cluster of 10 to 12 basal cells was immunopositive for vimentin, but the epithelium was overall negative and listed as such in <xref ref-type="table" rid="table1-0300985811427152">Table 1</xref>. The basement membrane was weakly immunoreactive for laminin. The stromal keratocytes were immunopositive for vimentin; 2 cases were immunoreactive for SMA and S100, mostly in the peripheral cornea. The stromal collagen was negative for all stains. Laminin was weakly immunoreactive on the stromal aspect of Descemet membrane in 2 cases. The corneal endothelium was immunoreactive for vimentin, SMA, and Melan-A, with 2 cases immunopositive for NSE and 1 case immunopositive for GFAP.</p>
<fig id="fig1-0300985811427152" position="float">
<caption>
<p><bold>Figure 1.</bold> Cornea; dog. (a) Normal histologic appearance. HE. (b) Positive immunoreaction in all layers of the epithelium with pan-cytokeratin (AE1/AE3). Immunoperoxidase, 3-amino-9-ethylcarbazole (AEC) chromogen, hematoxylin counterstain. (c) Positive immunoreaction in all layers of the epithelium with α–smooth muscle actin. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. <bold>Figure 2</bold> Iris; dog. (a) Normal histologic appearance. HE. (b) Positive immunoreaction in the dilator and constrictor muscles with α–smooth muscle actin. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. (c) Positive immunoreaction in the constrictor muscle with desmin; <bold>Figure 2. (continued).</bold> the dilator muscle is negative. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. <bold>Figure 3</bold> Ciliary epithelium, pars plicata; dog. (a) Normal histology. (b) Positive immunoreaction in the pigmented and nonpigmented ciliary epithelium with vimentin. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. (c) Positive immunoreaction in the nonpigmented ciliary epithelium with neuron-specific enolase. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. <bold>Figure 4</bold> Lens; dog. (a) Normal histologic appearance. HE. (b) Positive immunoreaction in the lens epithelium and fibers with vimentin. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. (c) Positive immunoreaction in the lens epithelium and fibers with α–smooth muscle actin. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. <bold>Figure 5</bold> Retina; dog. (a) Normal histologic appearance. HE. (b) Positive immunoreaction in the retinal pigment epithelium with AE1/AE3. Immunoperoxidase, AEC chromogen, hematoxylin counterstain. (c) Positive immunoreaction in the retinal pigment epithelium, multiple layers of the neuroretina, and choroid with vimentin. Immunoperoxidase, AEC chromogen, hematoxylin counterstain.</p>
</caption>
<graphic alternate-form-of="fig1-0300985811427152" xlink:href="10.1177_0300985811427152-fig1.tif"/>
</fig>
</sec>
<sec id="section7-0300985811427152">
<title>Iris</title>
<p>All stromal cells were immunoreactive for vimentin. Some stromal cells surrounding vessels were immunopositive for GFAP, and some diffusely scattered cells were immunopositive for laminin. The stromal melanocytes, including those forming the iris anterior border, were immunoreactive for vimentin and Melan-A. The constrictor muscle was immunoreactive for vimentin, laminin, and SMA; moderately reactive for MSA, desmin, and GFAP; and weakly positive for synaptophysin (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 2a–2c</xref>). The dilator muscle was immunoreactive for vimentin, laminin, and SMA; moderately reactive for MSA and GFAP; and weakly positive for synaptophysin (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 2a–2c</xref>). One case was positive for NSE. The iris posterior epithelium was immunoreactive for vimentin, NSE, and Melan-A.</p>
</sec>
<sec id="section8-0300985811427152">
<title>Ciliary Body</title>
<p>The cells lining the pectinate ligament were immunoreactive for vimentin and SMA, and 2 cases were positive for desmin. The basement membrane and extracellular matrix were multifocally weakly immunopositive for laminin. The cells lining the trabecular meshwork were immunopositive for vimentin, SMA, and desmin and weakly positive for S100. The basement membrane and extracellular matrix were multifocally weakly immunopositive for laminin. The immunophenotype of the ciliary epithelium in the pars plicata and pars plana were identical in all cases. The nonpigmented ciliary epithelium was immunoreactive for vimentin, moderately positive for NSE, and weakly positive for GFAP, desmin, and Melan-A. One case was weakly positive for synaptophysin (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 3a–3c</xref>). The internal limiting membrane / basement membrane was immunopositive for laminin. The pigmented ciliary epithelium was immunopositive for vimentin and moderately positive for GFAP in 2 cases (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 3a–3c</xref>). The basement membrane was immunopositive for laminin. The ciliary stromal cells were immunoreactive for vimentin, and some stromal cells were positive for desmin in 1 case. The melanocytes were vimentin and Melan-A reactive. The ciliary muscle was immunoreactive for vimentin, laminin, SMA, and MSA and moderately reactive for desmin, GFAP, and synaptophysin; 2 cases were positive for NSE.</p>
</sec>
<sec id="section9-0300985811427152">
<title>Choroid</title>
<p>All cells of the tapetum lucidum were immunoreactive for Melan-A. The stromal cells were vimentin immunopositive, and some of the stromal cells were reactive for SMA, MSA, and desmin. The melanocytes were vimentin and Melan-A reactive. The uveal (iris, ciliary body, and choroid) collagen/matrix was negative for all stains.</p>
</sec>
<sec id="section10-0300985811427152">
<title>Lens</title>
<p>The lens capsule was immunopositive for laminin in 2 cases. The lens epithelium was immunopositive for vimentin, SMA, desmin, S100, NSE, and GFAP (3 cases) (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 4a–4c</xref>). The cortical lens fibers were immunoreactive for vimentin, SMA, desmin, S100 (2 cases), and GFAP (3 cases). The lens nucleus and the lens zonules were negative for all stains.</p>
</sec>
<sec id="section11-0300985811427152">
<title>Retina</title>
<p>The nerve layer was immunoreactive for vimentin, S100, NSE, GFAP, and TNF. The ganglion cells were immunopositive for NSE and TNF, and 2 cases were positive for GFAP. The inner plexiform layer was immunopositive for vimentin, NSE, GFAP, synaptophysin, and TNF. There was multifocal immunoreactivity in the inner nuclear layer with vimentin, synaptophysin, NSE (2 cases), and TNF (2 cases). The outer plexiform layer was immunopositive for vimentin, NSE, synaptophysin, and TNF (3 cases). There was mutifocal immunoreaction in the outer nuclear layer with vimentin, NSE, and synaptophysin. The rod-cone layer was immunoreactive for NSE, synaptophysin, and TNF (3 cases). The RPE was immunopositive for vimentin and AE1/AE3 and weakly immunoreactive for CK8/18, Melan-A, and GFAP (3 cases) (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 5a–5c</xref>). The pigmented and nonpigmented RPE shared the same immunophenotype. The basement membrane was immunoreactive for laminin.</p>
</sec>
<sec id="section12-0300985811427152">
<title>Optic Nerve</title>
<p>The axons were immunoreactive for vimentin, NSE, GFAP, TNF, and S100 (2 cases). The glial cells were immunopositive for vimentin, GFAP, and S100 (2 cases). The meninges were immunoreactive for vimentin, SMA, laminin, NSE (3 cases), GFAP (2 cases), and desmin (1 case).</p>
</sec>
<sec id="section13-0300985811427152">
<title>Other Structures</title>
<p>Uveal and scleral peripheral nerves were immunoreactive for vimentin, S100, GFAP, TNF, and laminin, with SMA immunoreactivity limited to the sheath. The endothelium of blood vessels, including scleral veins, was immunopositive for vimentin and CD31 (immunoreactive in most vessels, weak reaction in veins). The walls of the blood vessels were immunoreactive for vimentin, SMA, desmin, MSA, and laminin. The scleral collagen was negative for all stains.</p>
</sec>
</sec>
<sec id="section14-0300985811427152">
<title>Discussion</title>
<p>The results of this study will serve as the basis for the future interpretation of neoplastic and nonneoplastic immunohistochemical studies performed on canine ocular diseases. In addition to selecting diagnostically relevant antibodies, we used a standard diagnostic protocol so that these results may be easily reproduced and so that results from other diagnostic laboratories may be more easily compared. As with any immunohistochemical study, the immunopositive reactions described here should be confirmed to be specific for each antibody by other methods. Our findings are compatible with the previous reports of positive immunohistochemical reaction in normal canine ocular structures (Supplemental Table 1). We did not observe SMA immunoreactivity in the ciliary epithelium as described by Zarfoss et al;<sup>
<xref ref-type="bibr" rid="bibr77-0300985811427152">77</xref>
</sup> however, there was positive desmin immunoreaction in the nonpigmented ciliary epithelium.</p>
<p>The broad spectrum of antibodies used in this study revealed several interesting immunophenotypes. The corneal and limbal conjunctival epithelia share a similar immunophenotype, which includes immunoreactivity for CKs (AE1/AE3 and CK8/18), SMA, and GFAP with variable S-100 and desmin immunoreactivity (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 1a–1c</xref>). One noteworthy difference between the corneal and conjunctival epithelia was the negative reactivity of the limbal basal cells for CK8/18, while the superficial limbal cells and all layers of the corneal epithelium were immunopositive. A similar distribution has been noted in humans with CK3/12, which supports the limbal localization of corneal stem cells.<sup>
<xref ref-type="bibr" rid="bibr42-0300985811427152">42</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>,<xref ref-type="bibr" rid="bibr65-0300985811427152">65</xref>
</sup> The distribution of CK8/18 in dogs may also be related to the unique role of limbal basal cells. The immunoreactivity of CKs was expected and is diagnostically helpful. However, the immunopositivity for muscle markers and GFAP in the limbal and corneal epithelia is an unexpected immunophenotype, one that is similar to proliferating/neoplastic myoepithelial cells.<sup>
<xref ref-type="bibr" rid="bibr27-0300985811427152">27</xref>,<xref ref-type="bibr" rid="bibr28-0300985811427152">28</xref>
</sup> The functional significance of these findings is unclear and warrants further investigation.</p>
<p>The cells lining the pectinate ligament and trabecular meshwork share a similar immunophenotype. Vimentin and SMA immunoreactivity is likely to be the most helpful in the study of pectinate ligament and trabecular meshwork cells. There is also desmin immunopositivity, and the trabecular meshwork cells are immunoreactive for S100. There is no positive immunoreaction with CD31, indicating that the cells lining the pectinate ligament and trabecular meshwork are not vascular in origin despite being often termed <italic>trabecular meshwork endothelium</italic>.<sup>
<xref ref-type="bibr" rid="bibr12-0300985811427152">12</xref>,<xref ref-type="bibr" rid="bibr76-0300985811427152">76</xref>
</sup> In humans, trabecular meshwork cells are negative for CD31 and CD34, but the cells lining Schlemm canal are immunopositive.<sup>
<xref ref-type="bibr" rid="bibr25-0300985811427152">25</xref>,<xref ref-type="bibr" rid="bibr73-0300985811427152">73</xref>
</sup>
</p>
<p>The distribution of the muscle markers in the dilator, constrictor (sphincter), and ciliary muscles is distinct. The constrictor and ciliary muscles are immunopositive for SMA, MSA, and desmin, while the iris dilator muscle is SMA and MSA immunopositive but desmin negative (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 2a–2c</xref>). A similar distribution of muscle markers has been described in cats and was shown to be diagnostically helpful to determine the origin of an intraocular leiomyosarcoma.<sup>
<xref ref-type="bibr" rid="bibr34-0300985811427152">34</xref>
</sup> The dilator, constrictor, and ciliary muscles were moderately immunoreactive for GFAP. This should be considered when making the diagnosis of uveal schwannomas / spindle cells tumors of blue-eyed dogs, which are GFAP immunopositive but negative for muscle markers (<xref ref-type="table" rid="table2-0300985811427152">Table 2</xref>).<sup>
<xref ref-type="bibr" rid="bibr79-0300985811427152">79</xref>
</sup> Numerous choroidal stromal cells are immunoreactive to all 3 muscle markers (SMA, MSA, desmin). It is possible that these cells are similar to the network of nonvascular smooth muscle cell of the choroid described in other species. The exact function is not known, but a role in the protection of choroidal architecture during accommodation has been proposed.<sup>
<xref ref-type="bibr" rid="bibr40-0300985811427152">40</xref>,<xref ref-type="bibr" rid="bibr56-0300985811427152">56</xref>
</sup>
</p>
<table-wrap id="table2-0300985811427152" position="float">
<label>Table 2.</label>
<caption>
<p>Previously Reported Diagnostic Immunohistochemistry of Primary Ocular Neoplasms in Dogs</p>
</caption>
<graphic alternate-form-of="table2-0300985811427152" xlink:href="10.1177_0300985811427152-table2.tif"/>
<table>
<thead>
<tr>
<th>Neoplasm (No. of Cases)</th>
<th>Positive Immunoreactivity<sup>a</sup> (No. of Cases)</th>
<th>Negative Stains (No. of Cases)</th>
<th>References</th>
</tr>
</thead>
<tbody>
<tr>
<td>Limbal hemangiosarcoma (1)</td>
<td>CD31</td>
<td>
</td>
<td><xref ref-type="bibr" rid="bibr14-0300985811427152">14</xref></td>
</tr>
<tr>
<td>Corneal squamous cell carcinoma (1)</td>
<td>Pan-CK, E-cadherin</td>
<td>
</td>
<td><xref ref-type="bibr" rid="bibr46-0300985811427152">46</xref></td>
</tr>
<tr>
<td>Iridociliary epithelial tumors (20)</td>
<td>Vimentin (18/20), NSE (8/8), Pan-CK (4/23), desmin (3/11), S100 (10/20), GFAP (1/20)</td>
<td>
</td>
<td><xref ref-type="bibr" rid="bibr15-0300985811427152">15</xref></td>
</tr>
<tr>
<td>Iridociliary adenoma (14)</td>
<td>Pan-CK (9/14), CK20 (7/14)</td>
<td>CK7 (0/14)</td>
<td><xref ref-type="bibr" rid="bibr33-0300985811427152">33</xref></td>
</tr>
<tr>
<td>Iridociliary adenocarcinoma (8)</td>
<td>Pan-CK (6/8), vimentin (1/1), NSE (1/1), S100 (1/1)</td>
<td>CK7 (0/7), CK20 (0/7)</td>
<td><xref ref-type="bibr" rid="bibr33-0300985811427152">33</xref>, <xref ref-type="bibr" rid="bibr78-0300985811427152">78</xref></td>
</tr>
<tr>
<td>Medulloepithelioma (8)</td>
<td>Pan-CK (1/7), GFAP (1/1)</td>
<td>CK7 (0/7), CK20 (0/7)</td>
<td><xref ref-type="bibr" rid="bibr33-0300985811427152">33</xref>, <xref ref-type="bibr" rid="bibr69-0300985811427152">69</xref></td>
</tr>
<tr>
<td>Malignant teratoid medulloepithelioma (1)</td>
<td>Vimentin, CD99</td>
<td>CK, NSE, TNF, GFAP, synaptophysin</td>
<td><xref ref-type="bibr" rid="bibr1-0300985811427152">1</xref></td>
</tr>
<tr>
<td>Uveal schwannoma/ peripheral nerve sheath tumor (14)</td>
<td>Vimentin (11/11), S100 (8/8), GFAP (9/13), PGP9.5 (7/9), laminin (2/9)</td>
<td>SMA (0/7), desmin (0/7), Melan-A (0/7), MITF (0/7), TNF (0/1)</td>
<td><xref ref-type="bibr" rid="bibr64-0300985811427152">64</xref>, <xref ref-type="bibr" rid="bibr79-0300985811427152">79</xref></td>
</tr>
<tr>
<td>Uveal malignant melanoma (1)</td>
<td>Melan-A</td>
<td>
</td>
<td><xref ref-type="bibr" rid="bibr19-0300985811427152">19</xref></td>
</tr>
<tr>
<td>Ocular melanosis (14)</td>
<td>Vimentin (8/8), HMB45 (8/8), MITF (8/8)</td>
<td>SMA (0/8), S100 (0/8), Melan-A (0/14), chromogranin A/B (0/8), PGP9.5 (0/8), synaptophysin (0/8), CK (0/8), CD45 (0/8)</td>
<td><xref ref-type="bibr" rid="bibr54-0300985811427152">54</xref>, <xref ref-type="bibr" rid="bibr72-0300985811427152">72</xref></td>
</tr>
<tr>
<td>Mixed germ cell tumor (1)</td>
<td>Pan-CK</td>
<td>
</td>
<td><xref ref-type="bibr" rid="bibr51-0300985811427152">51</xref></td>
</tr>
<tr>
<td>Myxoid leiomyoma of the iris (1)</td>
<td>Desmin</td>
<td>S100</td>
<td><xref ref-type="bibr" rid="bibr4-0300985811427152">4</xref></td>
</tr>
<tr>
<td>Retinoblastoma (1)</td>
<td>GFAP</td>
<td>
</td>
<td><xref ref-type="bibr" rid="bibr69-0300985811427152">69</xref></td>
</tr>
<tr>
<td>Neuroepithelial tumor of the retina (1)</td>
<td>Vimentin, synaptophysin</td>
<td>CK, GFAP, NSE, TNF, S100, CD56, CD99</td>
<td><xref ref-type="bibr" rid="bibr29-0300985811427152">29</xref></td>
</tr>
<tr>
<td>Retinal-optic nerve glioma/astrocytoma (20)</td>
<td>Vimentin (1/1), NSE (1/1), S100 (1/1), GFAP (18/20)</td>
<td>TNF (0/1), Melan-A (0/1)</td>
<td><xref ref-type="bibr" rid="bibr9-0300985811427152">9</xref>, <xref ref-type="bibr" rid="bibr43-0300985811427152">43</xref>, <xref ref-type="bibr" rid="bibr48-0300985811427152">48</xref></td>
</tr>
<tr>
<td>Orbital meningioma (14)</td>
<td>Vimentin (14/14), S100 (14/14), NSE (4/4), GFAP (1/4)</td>
<td>CK (0/14)</td>
<td><xref ref-type="bibr" rid="bibr39-0300985811427152">39</xref>, <xref ref-type="bibr" rid="bibr47-0300985811427152">47</xref>, <xref ref-type="bibr" rid="bibr53-0300985811427152">53</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0300985811427152">
<p>CK, cytokeratin; NSE, neuron-specific enolase; GFAP, glial fibrillary acidic protein; SMA, α–smooth muscle actin; MITF, microphthalmia transcription factor; TNF, triple neurofilament.</p>
</fn>
<fn id="table-fn7-0300985811427152">
<p>
<sup>a</sup>Positive immunoreaction in at least some neoplasms.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The use of vimentin, NSE, and GFAP appears to be the best diagnostic combination to identify canine neuroepithelium of the iris and ciliary body (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 3a–3c</xref>). The iris posterior epithelium is immunoreactive for vimentin, NSE, and Melan-A. The nonpigmented ciliary epithelium is immunoreactive for vimentin and NSE and weakly immunopositive for GFAP, desmin, Melan-A, and synaptophysin. The pigmented ciliary epithelium is immunopositive for vimentin and weakly immunoreactive for GFAP. These findings are consistent with previous published immunoreactivity in normal and neoplastic neuroepithelium (Supplemental Table 1, Table 2).<sup>
<xref ref-type="bibr" rid="bibr15-0300985811427152">15</xref>,<xref ref-type="bibr" rid="bibr16-0300985811427152">16</xref>
</sup> In humans, the ciliary epithelium is immunoreactive for vimentin as well as CK.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr55-0300985811427152">55</xref>
</sup>
</p>
<p>The normal canine lens epithelium is immunopositive for vimentin, SMA, desmin, S100, NSE, and GFAP (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 4a–4c</xref>). The immunoreactions with vimentin and possibly SMA are likely to be the most helpful in the study of the lens epithelium. Vimentin, SMA, S100, NSE, and GFAP immunoreactivity has been noted in the lens epithelium of different species in various combinations and at different times in development, but desmin immunoreactivity appears unique to the canine lens epithelium.<sup>
<xref ref-type="bibr" rid="bibr6-0300985811427152">6</xref>,<xref ref-type="bibr" rid="bibr20-0300985811427152">20</xref>,<xref ref-type="bibr" rid="bibr44-0300985811427152">44</xref>,<xref ref-type="bibr" rid="bibr45-0300985811427152">45</xref>,<xref ref-type="bibr" rid="bibr61-0300985811427152">61</xref>,<xref ref-type="bibr" rid="bibr68-0300985811427152">68</xref>,<xref ref-type="bibr" rid="bibr80-0300985811427152">80</xref>
</sup> The embryologic origin of the lens epithelium is the surface ectoderm, but CK immunoreactivity is lost in the early stages of lens development.<sup>
<xref ref-type="bibr" rid="bibr31-0300985811427152">31</xref>,<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>
</sup> There is no CK immunopositivity in the normal adult lens epithelium in most species.<sup>
<xref ref-type="bibr" rid="bibr31-0300985811427152">31</xref>,<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>
</sup> CK immunoreactivity has however been reported in the epithelium of lenses with cataracts.<sup>
<xref ref-type="bibr" rid="bibr11-0300985811427152">11</xref>,<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr70-0300985811427152">70</xref>
</sup> The positive immunoreaction of SMA in normal canine lens epithelial cells is significant, since SMA immunoreactivity has been used as an indication of epithelial-mesenchymal transition / metaplasia in cataract formation. It has been recently discovered that normal human lens epithelium is also immunoreactive to SMA and that epithelial-mesenchymal transition may be dependent on increased immunoreactivity of SMA and other factors rather than simply the presence of SMA.<sup>
<xref ref-type="bibr" rid="bibr11-0300985811427152">11</xref>,<xref ref-type="bibr" rid="bibr20-0300985811427152">20</xref>,<xref ref-type="bibr" rid="bibr21-0300985811427152">21</xref>,<xref ref-type="bibr" rid="bibr61-0300985811427152">61</xref>
</sup>
</p>
<p>It is best to interpret the results in the neuroretina as a descriptive distribution of immunoreaction rather than an identification of specific cell types, since we did not perform double labeling or use antibodies specific for the various cells of the retina. The CK reaction of the AE1/AE3 antibody described in glial cells and neural tissue and interpreted in most cases to be a cross-reaction with GFAP was not present in this study.<sup>
<xref ref-type="bibr" rid="bibr17-0300985811427152">17</xref>
</sup> The RPE is immunoreactive for both CKs (AE1/AE3 and weak reaction to CK8/18) and vimentin, and this is a diagnostic feature of the normal canine RPE (<xref ref-type="fig" rid="fig1-0300985811427152">Fig. 5a–5c</xref>). There is also weak immunoreaction for Melan-A and GFAP. This immunophenotype is compatible with previous findings in dogs and other species. Dual immunoreactivity for vimentin and CK has been shown in cultured canine RPE cells.<sup>
<xref ref-type="bibr" rid="bibr41-0300985811427152">41</xref>
</sup> Guinea pig RPE cells and a proportion of bovine RPE cells in situ also demonstrate both CK and vimentin IFs.<sup>
<xref ref-type="bibr" rid="bibr50-0300985811427152">50</xref>
</sup> Normal human adult RPE cells are only immunopositive CKs, but coreactivity of vimentin with CKs has been documented during ocular development and in reactive, hyperplastic, and neoplastic RPE.<sup>
<xref ref-type="bibr" rid="bibr6-0300985811427152">6</xref>,<xref ref-type="bibr" rid="bibr18-0300985811427152">18</xref>,<xref ref-type="bibr" rid="bibr24-0300985811427152">24</xref>,<xref ref-type="bibr" rid="bibr32-0300985811427152">32</xref>,<xref ref-type="bibr" rid="bibr71-0300985811427152">71</xref>
</sup> RPE of rhesus monkeys is immunopositive for vimentin and CK after retinal separation/detachment, but vimentin immunolabeling is not detected after long-term reattachment.<sup>
<xref ref-type="bibr" rid="bibr22-0300985811427152">22</xref>
</sup> Triple immunoreactivity for CK–vimentin–GFAP has been documented in cells thought to be RPE in epiretinal membranes and in cultured RPE cells in humans.<sup>
<xref ref-type="bibr" rid="bibr8-0300985811427152">8</xref>
</sup> Neoplastic human RPE can be immunoreactive for Melan-A.<sup>
<xref ref-type="bibr" rid="bibr24-0300985811427152">24</xref>
</sup>
</p>
<p>The immunopositivity of Melan-A in all layers of the tapetum lucidum is consistent with the suspicion that the tapetal cells in tapeta cellulosa are modified melanocytes.<sup>
<xref ref-type="bibr" rid="bibr7-0300985811427152">7</xref>,<xref ref-type="bibr" rid="bibr37-0300985811427152">37</xref>,<xref ref-type="bibr" rid="bibr49-0300985811427152">49</xref>
</sup> The lack of immunoreactivity to any other antibody tested, including vimentin, is puzzling. Vimentin filaments in melanocytes are thought to be involved in the movement of melanosomes.<sup>
<xref ref-type="bibr" rid="bibr10-0300985811427152">10</xref>,<xref ref-type="bibr" rid="bibr30-0300985811427152">30</xref>
</sup> The lack of vimentin may be a consequence of the specific structure and arrangement of melanosome-like rods in tapetal cells. The unique role of tapetal pigment in light reflection rather than absorption may also be a factor contributing to the unique immunophenotype of the tapetal cells.<sup>
<xref ref-type="bibr" rid="bibr7-0300985811427152">7</xref>,<xref ref-type="bibr" rid="bibr37-0300985811427152">37</xref>,<xref ref-type="bibr" rid="bibr49-0300985811427152">49</xref>,<xref ref-type="bibr" rid="bibr63-0300985811427152">63</xref>
</sup>
</p>
<p>Our findings are compatible with the published immunophenotypes of canine ocular neoplasms (Table 2). Melanocytic and iridociliary neoplasms are the 2 most common forms of primary ocular neoplasia.<sup>
<xref ref-type="bibr" rid="bibr15-0300985811427152">15</xref>
</sup> Iridociliary tumors in dogs have a unique immunophenotype with immunopositivity for vimentin and NSE and variable immunoreaction with desmin and GFAP.<sup>
<xref ref-type="bibr" rid="bibr15-0300985811427152">15</xref>
</sup> A subset of iridociliary tumors, more often in histologically malignant neoplasms, is also immunopositive for CK,<sup>
<xref ref-type="bibr" rid="bibr15-0300985811427152">15</xref>,<xref ref-type="bibr" rid="bibr33-0300985811427152">33</xref>,<xref ref-type="bibr" rid="bibr78-0300985811427152">78</xref>
</sup> which was not observed in normal iris and ciliary epithelium. Melan-A immunoreactivity, noted in normal iris and nonpigmented ciliary epithelium, has not been investigated in canine iridociliary tumors. Melan-A immunoreactivity has however been reported in a human adenoma of the nonpigmented ciliary epithelium.<sup>
<xref ref-type="bibr" rid="bibr52-0300985811427152">52</xref>
</sup> Although differentiation between iridociliary tumors and melanoma does not typically require immunohistochemistry, the immunoreactivity of Melan-A in the nonpigmented ciliary epithelium may pose a diagnostic challenge in rare cases of poorly differentiated neoplasms affecting the uveal tract. Investigation of the immunoreactivity of other melanocyte/melanoma markers, such as PNL2 and tyrosine-related proteins 1 and 2,<sup>
<xref ref-type="bibr" rid="bibr60-0300985811427152">60</xref>,<xref ref-type="bibr" rid="bibr66-0300985811427152">66</xref>
</sup> in normal and neoplastic ocular tissue might prove useful. The cells of ocular melanosis, considered by many to be a form of diffuse melanocytoma, have a unique immunophenotype that differs from normal melanocytes, with positive immunoreaction for vimentin and variable HMB-45 and MITF immunoreactivity but negative reaction with Melan-A.<sup>
<xref ref-type="bibr" rid="bibr54-0300985811427152">54</xref>,<xref ref-type="bibr" rid="bibr72-0300985811427152">72</xref>,<xref ref-type="bibr" rid="bibr75-0300985811427152">75</xref>
</sup>
</p>
<p>In summary, this study provides a comprehensive description of the immunohistochemical features of normal canine ocular structures. Although interesting immunophenotypes were identified, this study reveals significant overlap in the immunoreaction patterns of various structures in the canine globe. Interpretation of immunohistochemistry performed on canine eyes should always be made in context of histopathologic findings and with knowledge that adjacent ocular structures may share immunohistochemical characteristics. Further research is needed to validate these findings and provide functional significance to the immunophenotypes identified.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Dr Scott Moroff and Antech Diagnostics for providing funding for this study, as well as Marc Hardman for assistance with figures.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-0300985811427152">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0300985811427152">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0300985811427152">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aleksandersen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bjerkas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Heiene</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Malignant teratoid medulloepithelioma with brain and kidney involvement in a dog</article-title>. <source>Vet Ophthalmol</source>. <year>2004</year>;<volume>7</volume>:<fpage>407</fpage>–<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr2-0300985811427152">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barthez</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Pheochromocytoma in dogs: 61 cases (1984–1995)</article-title>. <source>J Vet Intern Med</source>. <year>1997</year>;<volume>11</volume>:<fpage>272</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr3-0300985811427152">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bentley</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Abrams</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Covitz</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Morphology and immunohistochemistry of spontaneous chronic corneal epithelial defects (SCCED) in dogs</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2001</year>;<volume>42</volume>:<fpage>2262</fpage>–<lpage>2269</lpage>.</citation>
</ref>
<ref id="bibr4-0300985811427152">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Billson</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Mould</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WR</given-names>
</name>
</person-group>. <article-title>Myxoid leiomyoma of the iris in a dog</article-title>. <source>Vet Ophthalmol</source>. <year>2003</year>;<volume>6</volume>:<fpage>173</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr5-0300985811427152">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonfanti</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Candeo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Piccinini</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Distribution of protein gene product 9.5 (PGP 9.5) in the vertebrate retina: evidence that immunoreactivity is restricted to mammalian horizontal and ganglion cells</article-title>. <source>J Comp Neurol</source>. <year>1992</year>;<volume>322</volume>:<fpage>35</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr6-0300985811427152">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozanic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bocina</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Saraga-Babic</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Involvement of cytoskeletal proteins and growth factor receptors during development of the human eye</article-title>. <source>Anat Embryol (Berl)</source>. <year>2006</year>;<volume>211</volume>:<fpage>367</fpage>–<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr7-0300985811427152">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bussow</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Baumgarten</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Hansson</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>The tapetal cell: a unique melanocyte in the tapetum lucidum cellulosum of the cat (felis domestica l.)</article-title>. <source>Anat Embryol (Berl)</source>. <year>1980</year>;<volume>158</volume>:<fpage>289</fpage>–<lpage>302</lpage>.</citation>
</ref>
<ref id="bibr8-0300985811427152">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casaroli-Marano</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Pagan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vilaro</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>1999</year>;<volume>40</volume>:<fpage>2062</fpage>–<lpage>2072</lpage>.</citation>
</ref>
<ref id="bibr9-0300985811427152">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caswell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Astrocytoma arising at the optic disc in a dog</article-title>. <source>Can Vet J</source>. <year>1999</year>;<volume>40</volume>:<fpage>427</fpage>–<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr10-0300985811427152">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barlan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>YH</given-names>
</name>
<etal/>
</person-group>. <article-title>The dynamic properties of intermediate filaments during organelle transport</article-title>. <source>J Cell Sci</source>. <year>2009</year>;<volume>122</volume>:<fpage>2914</fpage>–<lpage>2923</lpage>.</citation>
</ref>
<ref id="bibr11-0300985811427152">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colitz</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Malarkey</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dykstra</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Histologic and immunohistochemical characterization of lens capsular plaques in dogs with cataracts</article-title>. <source>Am J Vet Res</source>. <year>2000</year>;<volume>61</volume>:<fpage>139</fpage>–<lpage>143</lpage>.</citation>
</ref>
<ref id="bibr12-0300985811427152">
<label>12</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>CS</given-names>
</name>
</person-group>. <article-title>Ocular embryology and congenital malformations</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Gelatt</surname>
<given-names>KN</given-names>
</name>
</person-group>, ed. <source>Veterinary Ophthalmology</source>. <edition>4th ed</edition>. <publisher-loc>Ames, IA</publisher-loc>: <publisher-name>Blackwell</publisher-name>; <year>2007</year>:<fpage>3</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr13-0300985811427152">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coons</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Creech</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>RN</given-names>
</name>
</person-group>. <article-title>Immunological properties of an antibody containing a fluorescent group</article-title>. <source>Proc Soc Exp Biol Med</source>. <year>1941</year>;<volume>47</volume>:<fpage>200</fpage>–<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr14-0300985811427152">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donaldson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sansom</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Multiple limbal haemangiosarcomas in a border collie dog: management by lamellar keratectomy/sclerectomy and strontium-90 beta plesiotherapy</article-title>. <source>J Small Anim Pract</source>. <year>2006</year>;<volume>47</volume>:<fpage>545</fpage>–<lpage>549</lpage>.</citation>
</ref>
<ref id="bibr15-0300985811427152">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubielzig</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Garvin</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Iridociliary epithelial tumors in 100 dogs and 17 cats: a morphological study</article-title>. <source>Vet Ophthalmol</source>. <year>1998</year>;<volume>1</volume>:<fpage>223</fpage>–<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr16-0300985811427152">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Armour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mundy</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The histopathological and immunohistochemical characteristics of pigmentary and cystic glaucoma in the Golden Retriever</article-title>. <source>Vet Ophthalmol</source>. <year>2009</year>;<volume>12</volume>:<fpage>361</fpage>–<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr17-0300985811427152">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fanburg-Smith</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Majidi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miettinen</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Keratin expression in schwannoma; a study of 115 retroperitoneal and 22 peripheral schwannomas</article-title>. <source>Mod Pathol</source>. <year>2006</year>;<volume>19</volume>:<fpage>115</fpage>–<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr18-0300985811427152">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchs</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Kivela</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tarkkanen</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Cytoskeleton in normal and reactive human retinal pigment epithelial cells</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>1991</year>;<volume>32</volume>:<fpage>3178</fpage>–<lpage>3186</lpage>.</citation>
</ref>
<ref id="bibr19-0300985811427152">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin-Suarez</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Molleda</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Presumed primary uveal melanoma with brain extension in a dog</article-title>. <source>J Small Anim Pract</source>. <year>2009</year>;<volume>50</volume>:<fpage>306</fpage>–<lpage>310</lpage>.</citation>
</ref>
<ref id="bibr20-0300985811427152">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Beebe</surname>
<given-names>DC</given-names>
</name>
</person-group>. <article-title>Alpha-smooth muscle actin is constitutively expressed in the lens epithelial cells of several species</article-title>. <source>Exp Eye Res</source>. <year>2006</year>;<volume>83</volume>:<fpage>999</fpage>–<lpage>1001</lpage>.</citation>
</ref>
<ref id="bibr21-0300985811427152">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerardi</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Colitz</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Dubielzig</surname>
<given-names>RR</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunohistochemical analysis of lens epithelial-derived membranes following cataract extraction in the dog</article-title>. <source>Vet Ophthalmol</source>. <year>1999</year>;<volume>2</volume>:<fpage>163</fpage>–<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr22-0300985811427152">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerin</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Changes in intermediate filament immunolabeling occur in response to retinal detachment and reattachment in primates</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>1990</year>;<volume>31</volume>:<fpage>1474</fpage>–<lpage>1482</lpage>.</citation>
</ref>
<ref id="bibr23-0300985811427152">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Samuelson</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>PA</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunocytochemical localization of smooth muscle actin-containing cells in the trabecular meshwork of glaucomatous and nonglaucomatous dogs</article-title>. <source>Vet Ophthalmol</source>. <year>2007</year>;<volume>10</volume>(<issue>suppl 1</issue>):<fpage>38</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr24-0300985811427152">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heegaard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Fledelius</surname>
<given-names>HC</given-names>
</name>
<etal/>
</person-group>. <article-title>Neoplasia versus hyperplasia of the retinal pigment epithelium: a comparison of two cases</article-title>. <source>Acta Ophthalmol Scand</source>. <year>2001</year>;<volume>79</volume>:<fpage>626</fpage>–<lpage>633</lpage>.</citation>
</ref>
<ref id="bibr25-0300985811427152">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heimark</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Kaochar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stamer</surname>
<given-names>WD</given-names>
</name>
</person-group>. <article-title>Human Schlemm’s canal cells express the endothelial adherens proteins, VE-cadherin and PECAM-1</article-title>. <source>Curr Eye Res</source>. <year>2002</year>;<volume>25</volume>:<fpage>299</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr26-0300985811427152">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemesath</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Takemoto</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes</article-title>. <source>Nature</source>. <year>1998</year>;<volume>391</volume>:<fpage>298</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr27-0300985811427152">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirayama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kagawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsuzuki</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>A pleomorphic adenoma of the lacrimal gland in a dog</article-title>. <source>Vet Pathol</source>. <year>2000</year>;<volume>37</volume>:<fpage>353</fpage>–<lpage>356</lpage>.</citation>
</ref>
<ref id="bibr28-0300985811427152">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornick</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>CD</given-names>
</name>
</person-group>. <article-title>Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters</article-title>. <source>Am J Surg Pathol</source>. <year>2003</year>;<volume>27</volume>:<fpage>1183</fpage>–<lpage>1196</lpage>.</citation>
</ref>
<ref id="bibr29-0300985811427152">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Kaarsholm</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prause</surname>
<given-names>JU</given-names>
</name>
<etal/>
</person-group>. <article-title>Neuroepithelial tumor of the retina in a dog</article-title>. <source>Vet Ophthalmol</source>. <year>2003</year>;<volume>6</volume>:<fpage>57</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr30-0300985811427152">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jimbow</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>TB</given-names>
</name>
</person-group>. <article-title>Changes in distribution pattern of cytoplasmic filaments in human melanocytes during ultraviolet-mediated melanin pigmentation: the role of the 100-angstrom filaments in the elongation of melanocytic dendrites and in the movement and transfer of melanosomes</article-title>. <source>J Cell Biol</source>. <year>1975</year>;<volume>65</volume>:<fpage>481</fpage>–<lpage>488</lpage>.</citation>
</ref>
<ref id="bibr31-0300985811427152">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasper</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Viebahn</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Cytokeratin expression and early lens development</article-title>. <source>Anat Embryol (Berl)</source>. <year>1992</year>;<volume>186</volume>:<fpage>285</fpage>–<lpage>290</lpage>.</citation>
</ref>
<ref id="bibr32-0300985811427152">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kivela</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uusitalo</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Structure, development and function of cytoskeletal elements in non-neuronal cells of the human eye</article-title>. <source>Prog Retin Eye Res</source>. <year>1998</year>;<volume>17</volume>:<fpage>385</fpage>–<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr33-0300985811427152">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klosterman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Colitz</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>HL</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunohistochemical properties of ocular adenomas, adenocarcinomas and medulloepitheliomas</article-title>. <source>Vet Ophthalmol</source>. <year>2006</year>;<volume>9</volume>:<fpage>387</fpage>–<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr34-0300985811427152">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Labelle</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holmberg</surname>
<given-names>BJ</given-names>
</name>
</person-group>. <article-title>Ocular myxoid leiomyosarcoma in a cat</article-title>. <source>Vet Ophthalmol</source>. <year>2010</year>;<volume>13</volume>:<fpage>58</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr35-0300985811427152">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazarides</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Intermediate filaments as mechanical integrators of cellular space</article-title>. <source>Nature</source>. <year>1980</year>;<volume>283</volume>:<fpage>249</fpage>–<lpage>256</lpage>.</citation>
</ref>
<ref id="bibr36-0300985811427152">
<label>36</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Leong</surname>
<given-names>ASY</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>FJWM</given-names>
</name>
</person-group>. <article-title>Antibodies</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Leong</surname>
<given-names>ASY</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>FJWM</given-names>
</name>
</person-group>, eds. <source>Manual of Diagnostic Antibodies for Immunohistology</source>. <edition>2nd ed</edition>. <publisher-loc>London, UK</publisher-loc>: <publisher-name>Greenwich Medical Media Ltd</publisher-name>.; <year>2003</year>:<fpage>3</fpage>–<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr37-0300985811427152">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucchi</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Callegari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bortolami</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>The development of the rods in the tapetal cells of the cat</article-title>. <source>J Anat</source>. <year>1978</year>;<volume>127</volume>:<fpage>505</fpage>–<lpage>513</lpage>.</citation>
</ref>
<ref id="bibr38-0300985811427152">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matos</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Trufelli</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>de Matos</surname>
<given-names>MG</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunohistochemistry as an important tool in biomarkers detection and clinical practice</article-title>. <source>Biomark Insights</source>. <year>2010</year>;<volume>5</volume>:<fpage>9</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr39-0300985811427152">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mauldin</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Deehr</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hertzke</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Canine orbital meningiomas: a review of 22 cases</article-title>. <source>Vet Ophthalmol</source>. <year>2000</year>;<volume>3</volume>:<fpage>11</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr40-0300985811427152">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>CA</given-names>
</name>
</person-group>. <article-title>Nonvascular smooth muscle alpha-actin positive cells in the choroid of higher primates</article-title>. <source>Curr Eye Res</source>. <year>2003</year>;<volume>27</volume>:<fpage>1</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr41-0300985811427152">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLellan</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Bedford</surname>
<given-names>PG</given-names>
</name>
</person-group>. <article-title>The cytoskeletal intermediate filaments of canine retinal pigment epithelial cells in vivo and in vitro</article-title>. <source>Res Vet Sci</source>. <year>1997</year>;<volume>63</volume>:<fpage>245</fpage>–<lpage>251</lpage>.</citation>
</ref>
<ref id="bibr42-0300985811427152">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merjava</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brejchova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vernon</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytokeratin 8 is expressed in human corneoconjunctival epithelium, particularly in limbal epithelial cells</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2011</year>;<volume>52</volume>:<fpage>787</fpage>–<lpage>794</lpage>.</citation>
</ref>
<ref id="bibr43-0300985811427152">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyerholz</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>JS</given-names>
</name>
</person-group>. <article-title>Solitary retinal astrocytoma in a dog</article-title>. <source>Vet Pathol</source>. <year>2004</year>;<volume>41</volume>:<fpage>177</fpage>–<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr44-0300985811427152">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rende</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calogero</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunochemical detection of S-100 protein in non-nervous structures of the rabbit eye</article-title>. <source>Brain Res</source>. <year>1985</year>;<volume>332</volume>:<fpage>358</fpage>–<lpage>360</lpage>.</citation>
</ref>
<ref id="bibr45-0300985811427152">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rende</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lauriola</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunohistochemical localization of S-100-containing cells in non-nervous structures of the human eye</article-title>. <source>Cell Biol Int Rep</source>. <year>1986</year>;<volume>10</volume>:<fpage>765</fpage>–<lpage>773</lpage>.</citation>
</ref>
<ref id="bibr46-0300985811427152">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montiani-Ferreira</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kiupel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muzolon</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Corneal squamous cell carcinoma in a dog: a case report</article-title>. <source>Vet Ophthalmol</source>. <year>2008</year>;<volume>11</volume>:<fpage>269</fpage>–<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr47-0300985811427152">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montoliu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Histological and immunohistochemical study of 30 cases of canine meningioma</article-title>. <source>J Comp Pathol</source>. <year>2006</year>;<volume>135</volume>:<fpage>200</fpage>–<lpage>207</lpage>.</citation>
</ref>
<ref id="bibr48-0300985811427152">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naranjo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schobert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dubielzig</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Canine ocular gliomas: a retrospective study</article-title>. <source>Vet Ophthalmol</source>. <year>2008</year>;<volume>11</volume>:<fpage>356</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr49-0300985811427152">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ollivier</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Samuelson</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>DE</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative morphology of the tapetum lucidum (among selected species)</article-title>. <source>Vet Ophthalmol</source>. <year>2004</year>;<volume>7</volume>:<fpage>11</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr50-0300985811427152">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owaribe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kartenbeck</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rungger-Brandle</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytoskeletons of retinal pigment epithelial cells: interspecies differences of expression patterns indicate independence of cell function from the specific complement of cytoskeletal proteins</article-title>. <source>Cell Tissue Res</source>. <year>1988</year>;<volume>254</volume>:<fpage>301</fpage>–<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr51-0300985811427152">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson-Kane</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Schulman</surname>
<given-names>FY</given-names>
</name>
<name>
<surname>Santiago</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Mixed germ cell tumor in the eye of a dog</article-title>. <source>Vet Pathol</source>. <year>2001</year>;<volume>38</volume>:<fpage>712</fpage>–<lpage>714</lpage>.</citation>
</ref>
<ref id="bibr52-0300985811427152">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pecorella</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ciocci</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Modesti</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Adenoma of the non-pigmented ciliary epithelium: a rare intraocular tumor with unusual immunohistochemical findings</article-title>. <source>Pathol Res Pract</source>. <year>2009</year>;<volume>205</volume>:<fpage>870</fpage>–<lpage>875</lpage>.</citation>
</ref>
<ref id="bibr53-0300985811427152">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Orbital meningioma with a granular cell component in a dog, with extracranial metastasis</article-title>. <source>J Comp Pathol</source>. <year>2005</year>;<volume>133</volume>:<fpage>212</fpage>–<lpage>217</lpage>.</citation>
</ref>
<ref id="bibr54-0300985811427152">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petersen-Jones</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Mentzer</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Dubielzig</surname>
<given-names>RR</given-names>
</name>
<etal/>
</person-group>. <article-title>Ocular melanosis in the Cairn Terrier: histopathological description of the condition, and immunohistological and ultrastructural characterization of the characteristic pigment-laden cells</article-title>. <source>Vet Ophthalmol</source>. <year>2008</year>;<volume>11</volume>:<fpage>260</fpage>–<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr55-0300985811427152">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pitz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moll</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Intermediate-filament expression in ocular tissue</article-title>. <source>Prog Retin Eye Res</source>. <year>2002</year>;<volume>21</volume>:<fpage>241</fpage>–<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr56-0300985811427152">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poukens</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Glasgow</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Demer</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Nonvascular contractile cells in sclera and choroid of humans and monkeys</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>1998</year>;<volume>39</volume>:<fpage>1765</fpage>–<lpage>1774</lpage>.</citation>
</ref>
<ref id="bibr57-0300985811427152">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Vara</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Technical aspects of immunohistochemistry</article-title>. <source>Vet Pathol</source>. <year>2005</year>;<volume>42</volume>:<fpage>405</fpage>–<lpage>426</lpage>.</citation>
</ref>
<ref id="bibr58-0300985811427152">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Vara</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Beissenherz</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunoreactivity of A103, an antibody to Melan A, in canine steroid-producing tissues and their tumors</article-title>. <source>J Vet Diagn Invest</source>. <year>2001</year>;<volume>13</volume>:<fpage>328</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr59-0300985811427152">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Vara</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Beissenherz</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases</article-title>. <source>Vet Pathol</source>. <year>2000</year>;<volume>37</volume>:<fpage>597</fpage>–<lpage>608</lpage>.</citation>
</ref>
<ref id="bibr60-0300985811427152">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Vara</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Immunohistochemical identification of canine melanocytic neoplasms with antibodies to melanocytic antigen PNL2 and tyrosinase: comparison with Melan A</article-title>. <source>Vet Pathol</source>. <year>2011</year>;<volume>48</volume>:<fpage>443</fpage>–<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr61-0300985811427152">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rungger-Brandle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leuenberger</surname>
<given-names>PM</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression of alphasmooth muscle actin in lens epithelia from human donors and cataract patients</article-title>. <source>Exp Eye Res</source>. <year>2005</year>;<volume>81</volume>:<fpage>539</fpage>–<lpage>550</lpage>.</citation>
</ref>
<ref id="bibr62-0300985811427152">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryland</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Chisholm</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Localization of smooth muscle actin in the iridocorneal angle of normal and spontaneous glaucomatous beagle dogs</article-title>. <source>Vet Ophthalmol</source>. <year>2003</year>;<volume>6</volume>:<fpage>205</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr63-0300985811427152">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarna</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Properties and function of the ocular melanin: a photobiophysical view</article-title>. <source>J Photochem Photobiol B</source>. <year>1992</year>;<volume>12</volume>:<fpage>215</fpage>–<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr64-0300985811427152">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shibuya</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Intraocular peripheral nerve sheath tumor in a dog</article-title>. <source>Vet Ophthalmol</source>. <year>2005</year>;<volume>8</volume>:<fpage>283</fpage>–<lpage>286</lpage>.</citation>
</ref>
<ref id="bibr65-0300985811427152">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schermer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Galvin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>TT</given-names>
</name>
</person-group>. <article-title>Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells</article-title>. <source>J Cell Biol</source>. <year>1986</year>;<volume>103</volume>:<fpage>49</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr66-0300985811427152">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smedley</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Spangler</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Esplin</surname>
<given-names>DG</given-names>
</name>
<etal/>
</person-group>. <article-title>Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation</article-title>. <source>Vet Pathol</source>. <year>2011</year>;<volume>48</volume>:<fpage>54</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr67-0300985811427152">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Goldschmidt</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>McManus</surname>
<given-names>PM</given-names>
</name>
</person-group>. <article-title>A comparative review of melanocytic neoplasms</article-title>. <source>Vet Pathol</source>. <year>2002</year>;<volume>39</volume>:<fpage>651</fpage>–<lpage>678</lpage>.</citation>
</ref>
<ref id="bibr68-0300985811427152">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Landsbury</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dahm</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Functions of the intermediate filament cytoskeleton in the eye lens</article-title>. <source>J Clin Invest</source>. <year>2009</year>;<volume>119</volume>:<fpage>1837</fpage>–<lpage>1848</lpage>.</citation>
</ref>
<ref id="bibr69-0300985811427152">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syed</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Nork</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>GL</given-names>
</name>
<etal/>
</person-group>. <article-title>Retinoblastoma in a dog</article-title>. <source>Arch Ophthalmol</source>. <year>1997</year>;<volume>115</volume>:<fpage>758</fpage>–<lpage>763</lpage>.</citation>
</ref>
<ref id="bibr70-0300985811427152">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uusitalo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kivela</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Cell types of secondary cataract: an immunohistochemical analysis with antibodies to cytoskeletal elements and macrophages</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>. <year>1997</year>;<volume>235</volume>:<fpage>506</fpage>–<lpage>511</lpage>.</citation>
</ref>
<ref id="bibr71-0300985811427152">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uusitalo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kivela</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Development of cytoskeleton in neuroectodermally derived epithelial and muscle cells of the human eye</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>1995</year>;<volume>36</volume>:<fpage>2584</fpage>–<lpage>2591</lpage>.</citation>
</ref>
<ref id="bibr72-0300985811427152">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Sandt</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Boeve</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Stades</surname>
<given-names>FC</given-names>
</name>
<etal/>
</person-group>. <article-title>Abnormal ocular pigment deposition and glaucoma in the dog</article-title>. <source>Vet Ophthalmol</source>. <year>2003</year>;<volume>6</volume>:<fpage>273</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr73-0300985811427152">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hamanaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takemura</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Involvement of platelet coagulation and inflammation in the endothelium of Schlemm’s canal</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2010</year>;<volume>51</volume>:<fpage>277</fpage>–<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr74-0300985811427152">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Nadji</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Practical use of immunohistochemistry in surgical pathology</article-title>. <source>Jornal brasileiro de patologia e medicina laboratorial</source>. <year>2005</year>;<volume>41</volume>:<fpage>353</fpage>–<lpage>364</lpage>.</citation>
</ref>
<ref id="bibr75-0300985811427152">
<label>75</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wilcock</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dubielzig</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Render</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Intraocular tumors</article-title>. In: <source>World Health Organization Histologic Classification of Ocular and Otic Tumors of Domestic Animals</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>Armed Forces Institute of Pathology</publisher-name>; <year>2002</year>:<fpage>22</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr76-0300985811427152">
<label>76</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Yanoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sassani</surname>
<given-names>JW</given-names>
</name>
</person-group>. <article-title>Glaucoma</article-title>. <italic>In</italic>: <person-group person-group-type="editor">
<name>
<surname>Yanoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sassani</surname>
<given-names>JW</given-names>
</name>
</person-group>, eds. <source>Ocular Pathology</source>. <edition>6th ed</edition>. <publisher-loc>St-Louis, MO</publisher-loc>: <publisher-name>Mosby/Elsevier</publisher-name>; <year>2009</year>:<fpage>625</fpage>–<lpage>666</lpage>.</citation>
</ref>
<ref id="bibr77-0300985811427152">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarfoss</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Breaux</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Whiteley</surname>
<given-names>HE</given-names>
</name>
<etal/>
</person-group>. <article-title>Canine pre-iridal fibrovascular membranes: morphologic and immunohistochemical investigations</article-title>. <source>Vet Ophthalmol</source>. <year>2010</year>;<volume>13</volume>:<fpage>4</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr78-0300985811427152">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarfoss</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Dubielzig</surname>
<given-names>RR</given-names>
</name>
</person-group>. <article-title>Metastatic iridociliary adenocarcinoma in a labrador retriever</article-title>. <source>Vet Pathol</source>. <year>2007</year>;<volume>44</volume>:<fpage>672</fpage>–<lpage>676</lpage>.</citation>
</ref>
<ref id="bibr79-0300985811427152">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarfoss</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Klauss</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Newkirk</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Uveal spindle cell tumor of blue-eyed dogs: an immunohistochemical study</article-title>. <source>Vet Pathol</source>. <year>2007</year>;<volume>44</volume>:<fpage>276</fpage>–<lpage>284</lpage>.</citation>
</ref>
<ref id="bibr80-0300985811427152">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zwaan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Garza</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Neuron-specific enolase expression during eye development in the chicken embryo</article-title>. <source>Exp Eye Res</source>. <year>1994</year>;<volume>58</volume>:<fpage>91</fpage>–<lpage>97</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>